HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Non-steroidal topical immunomodulators provide skin-selective, self-limiting treatment in atopic dermatitis.

AbstractTopical corticosteroids are the mainstay of treatment for atopic dermatitis; however, their clinical utility is limited by potential side effects. Recently, the steroid-free topical immunomodulators tacrolimus ointment and pimecrolimus cream have become available. These agents provide effective treatment without causing skin atrophy or other steroidal side effects, and their physiochemical properties, such as relatively large molecular size and high lipophilicity, limit diffusion through skin and into the bloodstream, providing skin-selective treatment. Clinical trials with more than 1,700 paediatric and adult patients have demonstrated that treatment with either agent is associated with minimal systemic absorption of tacrolimus or pimecrolimus. Additionally, studies have shown that percutaneous absorption of tacrolimus decreases as treatment continues and clinical improvement occurs. This self-limiting facet of the treatment, together with the skin-selectivity of topical immunomodulators, is reflected in the good safety and tolerability profiles of these agents, which promise to significantly improve the long-term management of atopic dermatitis.
AuthorsJan D Bos (Affiliation: Department of Dermatology A0-235, Academic Medical Centre, University of Amsterdam, PO Box 22700, 1100 DE Amsterdam, The Netherlands. j.d.bos at amc.uva.nl)
JournalEuropean journal of dermatology : EJD (Eur J Dermatol) 2003 Sep-Oct Vol. 13 Issue 5 Pg. 455-61 ISSN: 1167-1122 [Print] France
PMID14693489 (Publication Type: Journal Article, Review)
Chemical References
  • Immunosuppressive Agents
  • pimecrolimus
  • Tacrolimus
Topics
  • Administration, Topical
  • Adolescent
  • Adult
  • Child
  • Clinical Trials as Topic
  • Dermatitis, Atopic (drug therapy)
  • Humans
  • Immunosuppressive Agents (administration & dosage, blood)
  • Skin (drug effects)
  • Tacrolimus (administration & dosage, analogs & derivatives, blood)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD